Antibodies aggravate the development of ischemic heart failure
Heart-specific antibodies have been widely associated with myocardial infarction (MI). However, it remains unclear whether autoantibodies mediate disease progression or are a byproduct of cardiac injury. To disambiguate the role of immunoglobulins in MI, we characterized the development of ischemic...
Autor principal: | |
---|---|
Outros Autores: | , , , , , |
Formato: | article |
Idioma: | eng |
Publicado em: |
2020
|
Assuntos: | |
Texto completo: | http://hdl.handle.net/10400.7/948 |
País: | Portugal |
Oai: | oai:arca.igc.gulbenkian.pt:10400.7/948 |